Please use this identifier to cite or link to this item:
Email to ask for this document in a different format
Title: Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.
Authors: Zühlke, Liesl J
Beaton, Andrea
Engel, Mark E
Hugo-Hamman, Christopher T
Karthikeyan, Ganesan
Katzenellenbogen, Judith M
Ntusi, Ntobeko
Ralph, Anna P
Saxena, Anita
Smeesters, Pierre R
Watkins, David
Zilla, Peter
Carapetis, Jonathan
Citation: Current treatment options in cardiovascular medicine 2017-02; 19(2): 15
Abstract: Early recognition of group A streptococcal pharyngitis and appropriate management with benzathine penicillin using local clinical prediction rules together with validated rapi-strep testing when available should be incorporated in primary health care. A directed approach to the differential diagnosis of acute rheumatic fever now includes the concept of low-risk versus medium-to-high risk populations. Initiation of secondary prophylaxis and the establishment of early medium to long-term care plans is a key aspect of the management of ARF. It is a requirement to identify high-risk individuals with RHD such as those with heart failure, pregnant women, and those with severe disease and multiple valve involvement. As penicillin is the mainstay of primary and secondary prevention, further research into penicillin supply chains, alternate preparations and modes of delivery is required.
Click to open PubMed article:
Click to open Pubmed Article:
Journal title: Current treatment options in cardiovascular medicine
Publication Date: 2017-02
ISSN: 1092-8464
Type: Journal Article
DOI: 10.1007/s11936-017-0513-y
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.